JAK2 mutants (e.g., JAK2V617F) and their importance as drug targets in myeloproliferative neoplasms

by Gäbler, Karoline, Behrmann, Iris, Haan, Claude
Published 2013

JAK2-V617F-induced MAPK activity is regulated by PI3K and acts synergistically with PI3K on the proliferation of JAK2-V617F-positive cells

by Wolf, Alexandra, Eulenfeld, René, Gäbler, Karoline, Rolvering, Catherine, Haan, Serge, Behrmann, Iris, Denecke, Bernd, Haan, Claude, Schaper, Fred
Published 2013

Cooperative effects of Janus and Aurora kinase inhibition by CEP701 in cells expressing Jak2V617F

by Gäbler, Karoline, Rolvering, Catherine, Kaczor, Jakub, Eulenfeld, René, Méndez, Sergio Álvarez, Berchem, Guy, Palissot, Valérie, Behrmann, Iris, Haan, Claude
Published 2013